Ex-Novartis worker seized for faking clinical trial data of blood pressure drug
A former employee of Novartis Pharma K.K. has been arrested for allegedly manipulating clinical study data for one of the company’s drugs.
The manipulation of clinical research data used to develop the blood pressure drug Diovan sold by Novartis Pharma K.K. has prompted a special squad of Tokyo prosecutors to search the Japanese unit of the Swiss drugmaker as well as the universities that conducted the ...
Tokyo prosecutors raided Novartis Pharma K.K. on Wednesday over its alleged use of exaggerated advertising for a blood pressure-lowering drug, following a criminal complaint filed by the health ministry last month. The ministry claimed that the ads for Diovan cited clinical study reports by two ...
A health ministry panel is questioning Novartis Pharma K.K.'s use of clinical research data in promoting the sale of Diovan, its drug to lower blood pressure, saying it "could constitute misleading advertisement" after revelations that some of the data were manipulated. The Japanese unit of ...
Novartis ordered to state skin disorders as Diovan side effects
The health ministry has instructed Novartis Pharma K.K. to state in an attached note for its Diovan blood pressure-lowering drug that the medicine may cause serious skin disorders. Diovan, whose generic name is valsartan, has been cited in a recent suspected case of clinical data ...
A Kyoto university's announcement that research on blood-pressure drug Diovan was manipulated raises concerns about the drugmaker's objectivity.
Markets flunk challenge of poor people's health
A lack of balance exists between the health needs of really poor people in the world and the market for helping the rich and super-rich lead a fashionable lifestyle.
